Pre-clinical validation of AAV-mediated gene therapy for KCNV2 retinopathy improves visual function and expression in mouse and patient models.

publication — a durable, citable reference into the African DSI DataBank's federated catalog.

Last updated 9/24/2026, 4:54:33 AM

Cite this record

African DSI DataBank. Pre-clinical validation of AAV-mediated gene therapy for KCNV2 retinopathy improves visual function and expression in mouse and patient models.. AFDSI-PUB-1168. 2026. https://hub.africandsidatabank.africa/cite/AFDSI-PUB-1168 Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42773706/.Copy citation

@misc{AFDSIPUB1168,
  title        = {Pre-clinical validation of AAV-mediated gene therapy for KCNV2 retinopathy improves visual function and expression in mouse and patient models.},
  author       = {{African DSI DataBank}},
  year         = {2026},
  howpublished = {\url{https://hub.africandsidatabank.africa/cite/AFDSI-PUB-1168}},
  note         = {African DSI DataBank citable identifier AFDSI-PUB-1168; Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42773706/}
}

AFDSI-PUB-1168 is a stable, resolvable local identifier — not a registered DOI. See Terms of use's "Citation policy" for the full explanation.